Portfolio company
ScoutBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
adivo
This biotechnology company develops species-specific therapeutic monoclonal antibodies for companion animals, primarily targeting cancer and inflammatory diseases in dogs and cats.
Gallant Pet
This biotechnology company develops regenerative stem cell therapies for domestic cats and dogs to treat chronic inflammatory and degenerative conditions.
Gallant Therapeutics
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
Gallant
The company develops ready-to-use mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
Rejuvenate Bio
The company develops gene therapies to treat age-related chronic diseases in humans and companion animals.